In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.
Infection of immunocompromised individuals with normally benign opportunistic viruses is a major health burden globally. Infections with viruses such as Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), Kaposi's sarcoma virus (KSHV), adenoviruses (AdV), BK virus (BKPyV), John Cunningham v...
Main Authors: | Douglas G Widman, Savanna Gornisiewicz, Sharon Shacham, Sharon Tamir |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6192554?pdf=render |
Similar Items
-
Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection.
by: Olivia Perwitasari, et al.
Published: (2016-01-01) -
Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth.
by: Hiromi I Wettersten, et al.
Published: (2014-01-01) -
Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related Lymphoma
by: Eline Boons, et al.
Published: (2015-09-01) -
Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
by: Abbey R. Sadowski, et al.
Published: (2018-08-01) -
XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor
by: Lijia Pan, et al.
Published: (2021-08-01)